CA
HCAT icon

CoreCap Advisors’s Health Catalyst HCAT Stock Holding History

CoreCap Advisors’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2
Closed -$7 – 2957
2025
Q1 		$7 Buy
+2
New +$11 ﹤0.01% 3125
2024
Q4 		– Sell
-647
Closed -$5.27K – 2911
2024
Q3 		$5.27K Hold
647
– – ﹤0.01% 1964
2024
Q2 		$4.13K Buy
+647
New +$4.15K ﹤0.01% 1199
2022
Q3 		– Sell
-120
Closed -$2K – 1166
2022
Q2 		$2K Buy
+120
New +$2.05K ﹤0.01% 1863
2022
Q1 		– Sell
-120
Closed -$5K – 1172
2021
Q4 		$5K Buy
+120
New +$5.47K ﹤0.01% 1747

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return